GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.

NEW YORK and SAN DIEGO, March 16, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics ("GenMark") (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark's agreement  to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share.

If you currently hold shares of GenMark, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com.

Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this investigation or have any questions regarding your rights and interests in this matter, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Gregory Stone, Director of Case and Financial Analysis
Kevin Cooper, Esq.
Email: gstone@whafh.com or classmember@whafh.com 
Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

View original content to download multimedia:http://www.prnewswire.com/news-releases/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman--herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd-301248877.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP